Antibacterial Protein LL-37 (human) CAS NO.154947-66-7

Antibacterial Protein LL-37 (human) CAS NO.154947-66-7

Antibacterial Protein LL-37 (human) CAS NO.154947-66-7

Antibacterial Protein LL-37 (human) CAS NO.154947-66-7

Antibacterial Protein LL-37 (human) CAS NO.154947-66-7

Antibacterial Protein LL-37 (human) (CAS NO. 154947-66-7) is a synthetic peptide corresponding to the 37-amino acid, C-terminal antimicrobial domain of the human cathelicidin antimicrobial peptide (hCAP-18). LL-37 is the only cathelicidin-derived peptide found in humans. It is a critical component of the innate immune system, exhibiting broad-spectrum antimicrobial activity against bacteria, fungi, and viruses. Beyond its direct microbial killing, LL-37 also acts as an immunomodulator, wound healing promoter, and anti-endotoxin agent, making it a versatile tool for research in immunology, dermatology, and infectious diseases.



TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
 Antibacterial Protein LL-37
CAS NO.
154947-66-7
Appearance
White to off-white lyophilized powder
Molecular Formula
C₂₀₅H₃₄₀N₆₀O₅₃
Molecular Weight
 4493.34g/mol
Purity (RP-HPLC)
≥ 95.0%
Solubility

Soluble in water (≥5 mg/mL); also soluble in 5% acetic acid or DMSO

Endotoxin< 1.0 EU/mg
Biological Activity
Broad-spectrum antimicrobial peptide ; neutralizes LPS, induces chemotaxis of immune cells , promotes wound healing, and exhibits anti-inflammatory/immunomodulatory effects.
Storage Conditions
Store at -20°C (long-term: -80°C for up to 2 years); avoid repeated freeze-thaw cycles; store as aliquots in sealed vials, protected from light and moisture
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

LL-37 is an amphipathic, α-helical cationic peptide that exerts its effects through multiple mechanisms:
  1. Membrane Disruption (Primary Antimicrobial Action): Its cationic nature is attracted to the anionic surfaces of microbial membranes. It adopts an amphipathic α-helical structure that integrates into and disrupts the microbial membrane, forming pores or causing general bilayer disintegration, leading to cell lysis and death. This mechanism makes it difficult for microbes to develop resistance.
  2. Immunomodulation: It acts as a chemoattractant for immune cells (neutrophils, monocytes, T-cells). It can neutralize bacterial endotoxins (LPS), reducing septic shock responses. It also modulates the production of cytokines and chemokines, influencing both pro- and anti-inflammatory pathways.
  3. Wound Healing & Angiogenesis: It promotes re-epithelialization, angiogenesis (blood vessel formation), and cell proliferation (e.g., in keratinocytes and endothelial cells) by activating growth factor receptors and signaling pathways.
  4. Biofilm Disruption: It can inhibit the formation and help break down established bacterial biofilms, a major challenge in chronic infections.

 

2.PRODUCT INDICATIONS

This product is indicated for advanced research in immunology, microbiology, dermatology, and drug discovery. Key applications include:
  • Innate Immunity & Host Defense Studies: Researching the role of antimicrobial peptides in the first line of defense against infection.
  • Antimicrobial & Antibiofilm Research: As a positive control or lead compound for studying novel antimicrobial strategies, especially against multidrug-resistant pathogens and biofilms.
  • Wound Healing & Dermatology: Investigating mechanisms of skin barrier function, psoriasis (where LL-37 is upregulated), atopic dermatitis (often downregulated), and chronic wound models.
  • Immunomodulation & Sepsis Research: Studying its role in modulating inflammation, neutralizing LPS, and its potential in sepsis models.
  • Drug Discovery: As a template for designing stable, potent, and selective antimicrobial peptide (AMP) analogs with improved therapeutic profiles.
 processes in pest insects.


3.CLINICAL EFFICACY OF PRODUCT

LL-37 itself is in various stages of clinical investigation for different indications, demonstrating its significant translational potential.
  • Topical Wound Healing: Clinical trials have shown that topical LL-37 (or analogs) can promote healing of venous leg ulcers and diabetic foot ulcers.
  • Infectious Disease: It is being explored for topical treatment of infected wounds, burns, and acne vulgaris due to its broad-spectrum activity and antibiofilm effects.
  • Autoimmune Disease (Psoriasis): Its role in psoriatic plaques is complex, and modulation of its activity is a therapeutic target.
  • Oral Mucositis: Clinical studies are investigating its efficacy in preventing or treating oral mucositis in cancer patients undergoing chemotherapy/radiation.
  • Research Validation: Countless preclinical studies validate its efficacy in models of infection, wound healing, and inflammation, solidifying its status as a key endogenous therapeutic peptide.


4.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods 
Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
Clinical Benefits and Production of Oxandrolone Steroid
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.